EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Blood–Brain Barrier Changes and Related Microvascular Outcomes in Long-COVID: A Comprehensive Review

Marcella Chagas-Sena iD, Wei Ling Lau iD, Thomas Edward Lane iD, Paola Cristina Resende iD, Ane Claudia Fernandes Nunes iD

Life · 24.07.2026 · 16 (8) · 1227

DOI: 10.3390/life16081227 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 24.07.2026. Verfasst von Marcella Chagas-Sena und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nova Friburgo Health Institute, Fluminense Federal University, Nova Friburgo 28625-650, Brazil. Die Arbeit nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Caused by the SARS-CoV-2 virus, the COVID-19 pandemic is still considered a complex challenge, with manifestations not only of respiratory issues, but also conditions related to chronic cerebrovascular damage. Endothelial biomarkers, neuropathological and neuroimaging findings indicate endothelial dysfunction, microthrombosis, and disruption of the blood–brain barrier (BBB) are central mechanisms for acute and chronic ischemic and hemorrhagic cerebral events. Understanding these mechanisms is vital to reducing their impact on population health, whether through treatment or prevention of adverse outcomes. The objective of this study is to perform a review of the scientific literature on the post-infection effects of SARS-CoV-2 affecting the cerebral endothelium and the BBB, correlating them with potential clinical outcomes. Material and Methods: Analysis of studies extracted from the PubMed database using the following terms: Long-COVID “AND” SARS-CoV-2 “AND” blood–brain barrier. Inclusion criteria: keywords, publications related to the topic, and primary studies published after peer review. Exclusion criteria: preprint studies, publication outside of the timeframe 2020–2025, study design not compatible with this research, and full text not available.

Results

An initial 121 studies were identified, of which 105 were excluded due to not meeting all inclusion criteria and 6 studies were inaccessible due to not being in the English language and full-text access limitations. Fifteen articles were included in the analysis, for topics as expression of viral receptors in the endothelium, markers of their activation, cerebral microvascular injury and coagulopathies. To clarify the pathogenic cascade, the evidence was stratified by biological model where in vitro evidence demonstrates that the Spike protein induces direct endothelial toxicity and platelet aggregation, establishing the primary molecular insult. Animal models confirm the translation of this insult into structural degradation of the BBB and pericyte loss. Clinically, infection-phase findings, characterized by multifocal microthrombosis and permeability spikes, act as the determining event that predisposes to the persistent neuroinflammatory environment. Biomarkers of BBB disruption and neuronal damage were consistently reported, with persistence of BBB dysfunction modifying risk stratification and rehabilitation efforts. Reported cases of Long-COVID demonstrated normalization of BBB markers without correlation with long-term symptoms, suggesting that other mechanisms are involved in Long-COVID.

Conclusion

Cerebral endotheliopathies and BBB dysfunction in patients with COVID-19 continue to impact the health of the population. The scientific literature indicates that SARS-CoV-2 induces cerebral endothelial injury, BBB disruption, and an increased risk of vascular events related to endotheliopathy, inflammation, and hypercoagulability. Understanding the impact of COVID-19 pathology on the population and developing prospective studies is essential to quantify the prevalence and mechanisms of brain injury. The identification of molecular targets and infection pathways are promising toward defining both preventive and therapeutic strategies to improve outcomes in the Long-COVID population.

Schlagwörter

Stichwörter der Autor:innen

Blood–Brain Barrier (BBB)Long-COVIDPost-Acute Sequelae of COVID-19 (PASC)SARS-CoV-2

Autor:innen und Institutionen

  • Nova Friburgo Health Institute, Fluminense Federal University, Nova Friburgo 28625-650, Brazil.
  • Division of Nephrology, Department of Medicine, University of California, Irvine, CA 92868, USA.
  • Department of Neurobiology & Behavior, University of California, Irvine, CA 92697, USA.
  • Laboratory of Respiratory, Exanthematous, Enteric Viruses and Viral Emergencies, Oswaldo Cruz Institute, Rio De Janeiro 21040-900, Brazil.
  • Laboratory of Cellular, Genetic, and Molecular Nephrology, Renal Division, Faculty of Medicine, University of São Paulo, São Paulo 01246-903, Brazil.

ORCID-Profile: Marcella Chagas-Sena, Wei Ling Lau, Thomas Edward Lane, Paola Cristina Resende, Ane Claudia Fernandes Nunes

Zitieren

APA

Chagas-Sena, M., Lau, W. L., Lane, T. E., Resende, P. C., & Nunes, A. C. F. (2026). Blood–Brain Barrier Changes and Related Microvascular Outcomes in Long-COVID: A Comprehensive Review. Life, 16(8), 1227. https://doi.org/10.3390/life16081227

Vancouver

Chagas-Sena M, Lau WL, Lane TE, Resende PC, Nunes ACF. Blood–Brain Barrier Changes and Related Microvascular Outcomes in Long-COVID: A Comprehensive Review. Life. 2026;16(8):1227. doi:10.3390/life16081227

BibTeX
@article{ChagasSena2026,
  author = {Chagas-Sena, Marcella and Lau, Wei Ling and Lane, Thomas Edward and Resende, Paola Cristina and Nunes, Ane Claudia Fernandes},
  title = {Blood–Brain Barrier Changes and Related Microvascular Outcomes in Long-COVID: A Comprehensive Review},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1227},
  doi = {10.3390/life16081227}
}
Kostenlos starten →